Growth & profitability
- Revenue has grown 3.5% per year over the past 4 years.
- Operating margin has contracted, at -226.9% in the latest year.
NIVF Financials NewGenIvf Group Ltd
5 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
RevenueNet income
GrossOperatingNet
Free cash flow
CashTotal debt
OperatingInvestingFinancing
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $5M | $10M | 20.2% | -226.9% | -$11M | — | $758621 |
| 2024 | $5M | -$524643 | 33.6% | -21.4% | -$8M | — | $457740 |
| 2023 | $5M | $130193 | 32.7% | 0.8% | -$2M | — | $54104 |
| 2022 | $6M | $458667 | 25.9% | 6.7% | $2M | — | $27556 |
| 2021 | $4M | -$533 | 24.9% | 4.8% | $1M | — | — |
Valuation over time
How the market has priced NIVF against its own fundamentals since 2024-04 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has fallen from 44.2× (Apr '24) to 8.2× (Nov '24).
- The price-to-sales ratio has fallen from 1.1× (Apr '24) to 0.4× (Jun '26).
P/E
P/S
Frequently asked questions
Is NIVF growing its revenue and profit?
Over the past 4 years, NewGenIvf Group Ltd's revenue has grown 3.5% per year. These are computed facts, not advice.
How much debt does NIVF have?
As of FY2025, NewGenIvf Group Ltd reported — of total debt against $758621 of cash.
What is NIVF's profit margin?
In FY2025, gross margin was 20.2%, operating margin -226.9%, and net margin 209.0%.
What is NIVF's P/E ratio?
As of Jun '26, NewGenIvf Group Ltd traded at a price-to-earnings ratio of about 8.2× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.